Introduction

All pharmaceutical companies strive to increase their profitability. But the goal is becoming increasingly harder to achieve as the industry faces a number of pressures:

Prices - Difficult to sustain, as competitor activity intensifies. Government constraints abound and generic substitutions are increasing.

R & D - NDA output has diminished. As the cost of science increases, and clinical trials and process development intensify, the overall cost of R&D is unlikely to decline.

Marketing - Costs are likely to increase through additional sales and promotion activities to support lifestyle and consumer type products.

Against this background, manufacturing has a unique opportunity to improve company profitability. Whilst compliance, quality, time to market and customer service remain as fundamental goals, productivity of technical operations must assume a higher profile.

Blockbuster Manufacturing is a proven business tool consisting of:

  • a structured implementation process,
  • a series of strategic and operational initiatives
  • a range of supporting templates
  • an organisational development methodology

Blockbuster Pharmaceutical Manufacturing
"a proven business tool that delivers productivity improvements and financial benefits throughout the global supply chain"

Available as a 350-page colour publication in a "pictures and notes" format.

One-day seminars on Blockbuster Pharmaceutical Manufacturing are also available. Please register your interest.
  Register your interest